Qiangda Chen

630 total citations
27 papers, 431 citations indexed

About

Qiangda Chen is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Qiangda Chen has authored 27 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Immunology and 7 papers in Surgery. Recurrent topics in Qiangda Chen's work include Pancreatic and Hepatic Oncology Research (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Pancreatitis Pathology and Treatment (5 papers). Qiangda Chen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Pancreatitis Pathology and Treatment (5 papers). Qiangda Chen collaborates with scholars based in China, United States and Japan. Qiangda Chen's co-authors include Ning Pu, Hanlin Yin, Wenchuan Wu, Wenhui Lou, Guochao Zhao, Wenhui Lou, Jun Yu, Dansong Wang, Siyao Liu and Xuefeng Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cancer and Advanced Science.

In The Last Decade

Qiangda Chen

25 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiangda Chen China 12 249 163 99 64 60 27 431
Vichnou Poirier-Colame France 8 212 0.9× 291 1.8× 159 1.6× 28 0.4× 40 0.7× 9 529
Dmitrij Ostroumov Germany 5 337 1.4× 294 1.8× 137 1.4× 31 0.5× 63 1.1× 6 526
Filippo Cortesi Italy 10 171 0.7× 174 1.1× 151 1.5× 14 0.2× 51 0.8× 13 397
Nicholas A. Zorko United States 11 165 0.7× 176 1.1× 104 1.1× 34 0.5× 39 0.7× 31 470
Mengyi Lao China 9 215 0.9× 105 0.6× 133 1.3× 66 1.0× 42 0.7× 21 351
Jessica C. Petrov United States 13 242 1.0× 159 1.0× 216 2.2× 58 0.9× 28 0.5× 22 476
Huanle Gong China 11 178 0.7× 423 2.6× 104 1.1× 56 0.9× 24 0.4× 19 543
Dimitrios Alatzoglou Switzerland 2 246 1.0× 198 1.2× 137 1.4× 12 0.2× 30 0.5× 3 409

Countries citing papers authored by Qiangda Chen

Since Specialization
Citations

This map shows the geographic impact of Qiangda Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiangda Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiangda Chen more than expected).

Fields of papers citing papers by Qiangda Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiangda Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiangda Chen. The network helps show where Qiangda Chen may publish in the future.

Co-authorship network of co-authors of Qiangda Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Qiangda Chen. A scholar is included among the top collaborators of Qiangda Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiangda Chen. Qiangda Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yin, Hanlin, Qiangda Chen, Yaolin Xu, et al.. (2025). The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor‐Intrinsic PD‐1/c‐MET Signaling in Pancreatic Cancer. Advanced Science. 12(36). e00806–e00806. 1 indexed citations
3.
Liu, Xiaolong, et al.. (2025). The CD39-CD73-adenosine axis: Master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(5). 189443–189443.
4.
Chen, Qiangda, Hanlin Yin, Siyao Liu, et al.. (2024). Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer. Journal for ImmunoTherapy of Cancer. 12(3). e008694–e008694. 8 indexed citations
5.
6.
Chen, Qiangda, Hanlin Yin, Junyi He, et al.. (2023). Tumor Microenvironment Responsive CD8+ T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for Pancreatic Cancer. Advanced Science. 10(33). e2302498–e2302498. 17 indexed citations
7.
Liu, Siyao, Wenchuan Wu, Hanlin Yin, et al.. (2023). The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications. Molecular Cancer. 22(1). 148–148. 52 indexed citations
8.
Chen, Qiangda, et al.. (2023). Biological and clinical implications of early-onset cancers: A unique subtype. Critical Reviews in Oncology/Hematology. 190. 104120–104120. 10 indexed citations
9.
Chen, Qiangda, et al.. (2023). Cancer-associated fibroblasts in neoadjuvant setting for solid cancers. Critical Reviews in Oncology/Hematology. 193. 104226–104226. 4 indexed citations
10.
Chen, Qiangda, Hanlin Yin, Siyao Liu, et al.. (2022). Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma. Journal for ImmunoTherapy of Cancer. 10(12). e005798–e005798. 44 indexed citations
11.
Pu, Ning, Qiangda Chen, Hanlin Yin, et al.. (2022). Identification of an Immune-Related BAT Signature for Predicting Adjuvant Chemotherapy Response and Overall Survival in Patients with Resected Ductal Adenocarcinoma of the Pancreas. Journal of Gastrointestinal Surgery. 26(4). 869–886. 9 indexed citations
12.
Chen, Qiangda, et al.. (2021). Chemokine C‐C motif ligand 21 synergized with programmed death‐ligand 1 blockade restrains tumor growth. Cancer Science. 112(11). 4457–4469. 10 indexed citations
13.
Yin, Hanlin, Ning Pu, Qiangda Chen, et al.. (2021). Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer. Cell Death and Disease. 12(11). 1033–1033. 60 indexed citations
14.
Chen, Qiangda, Ning Pu, Hanlin Yin, et al.. (2021). A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer. Experimental Biology and Medicine. 247(2). 120–130. 4 indexed citations
15.
Yin, Hanlin, et al.. (2021). Basophils as a potential therapeutic target in cancer. Journal of Zhejiang University SCIENCE B. 22(12). 971–984. 11 indexed citations
16.
Pu, Ning, Qiangda Chen, Wei Gan, et al.. (2021). Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma. Advances in Therapy. 38(8). 4258–4270. 11 indexed citations
17.
Pu, Ning, et al.. (2021). Current status and future perspectives of clinical research in pancreatic cancer: Establishment of evidence by science. Journal of Hepato-Biliary-Pancreatic Sciences. 29(7). 741–757. 7 indexed citations
18.
Li, Bo, Ning Pu, Qiangda Chen, et al.. (2021). Comprehensive Diagnostic Nomogram for Predicting Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy. Frontiers in Oncology. 11. 717087–717087. 11 indexed citations
19.
Pu, Ning, Joseph R. Habib, Michael Bejjani, et al.. (2021). The effect of primary site, functional status and treatment modality on survival in gastroenteropancreatic neuroendocrine neoplasms with synchronous liver metastasis: a US population-based study. Annals of Translational Medicine. 9(4). 329–329. 7 indexed citations
20.
Pu, Ning, Qiangda Chen, Shanshan Gao, et al.. (2019). Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. Annals of Translational Medicine. 7(22). 645–645. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vichnou Poirier-Colame Breakdown of academic impact, for papers by Dmitrij Ostroumov Breakdown of academic impact, for papers by Filippo Cortesi Breakdown of academic impact, for papers by Nicholas A. Zorko Breakdown of academic impact, for papers by Mengyi Lao Breakdown of academic impact, for papers by Jessica C. Petrov Breakdown of academic impact, for papers by Huanle Gong Breakdown of academic impact, for papers by Dimitrios Alatzoglou
Rankless by CCL
2026